Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

Conditions: Hepatorenal Syndrome; Liver Cirrhosis; Acute Kidney Injury; Ascites Hepatic Interventions: Drug: Ambrisentan; Drug: Terlipressin Sponsors: Noorik Biopharmaceuticals AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials